by Team Small News | Jun 17, 2025 | Pfizer, Pharma
Pfizer has recently secured the global rights outside of China for 3SBio’s dual-target cancer therapy, SSGJ-707. This deal marks a significant collaboration between the two companies, with Pfizer gaining exclusive rights to develop, manufacture, and... by Team Small News | Jun 17, 2025 | Fortis, Pharma
The bidding process for Sahyadri Hospitals, a multispecialty hospital chain, is nearing its deadline of June 22. Interested bidders, including Manipal Health Enterprises and Fortis Healthcare, are in talks with foreign lenders to secure financing of up to Rs 5,000... by Team Small News | Jun 16, 2025 | Pfizer, Pharma
A US Food and Drug Administration (FDA) advisory panel has rejected Pfizer’s bid to expand the use of its breast cancer drug, Talzenna (talazoparib). The panel voted against approving the medication for use in patients with a type of breast cancer known as... by Team Small News | Jun 16, 2025 | Apollo Hospital, Pharma
Dr. Prathap C. Reddy is a 92-year-old man who still goes to office every day, six days a week, and is the guiding force behind Apollo Hospitals, India’s largest healthcare network. He founded Apollo Hospitals in 1983, which was India’s first corporate... by Team Small News | Jun 16, 2025 | Fortis, Pharma
Fortis Healthcare, a leading integrated healthcare delivery service provider, has launched a super-speciality outpatient clinic in Guwahati, Assam. The clinic, which is the first of its kind in the region, aims to provide access to quality healthcare services to the... by Team Small News | Jun 15, 2025 | Pfizer, Pharma
A US Food and Drug Administration (FDA) advisory panel has rejected Pfizer’s bid to expand the use of its drug Talzenna (talazoparib) to treat metastatic prostate cancer. The panel’s decision was based on the results of a clinical trial that failed to show...